Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artículo científico |
| Lingua: | en |
| Pubblicazione: |
Centro de investigaciones y Publicaciones Farmacéuticas
2007
|
| Soggetti: | |
| Accesso online: | https://www.redalyc.org/articulo.oa?id=69050204 https://www.redalyc.org/journal/690/69050204/ https://www.redalyc.org/journal/690/69050204/html/ https://www.redalyc.org/journal/690/69050204/69050204.epub https://www.redalyc.org/journal/690/69050204/movil |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Sommario:
- Investigation of barriers to clinical practice guideline-recommended pharmacotherapy in the treatment of COPD Lea Price Sarah J. Billups Melissa A. Rice Cynthia Hartsfield Medicina Drug Therapy United States Pulmonary Disease Patient Compliance Practice Guidelines Background: The adoption of clinical practiceguideline recommendations for COPD issuboptimal. Determining the barriers to theimplementation of these practice guidelines mayhelp improve patient care.Objective: To determine whether barriers to the useof pharmacotherapy according to practiceguidelines are related primarily to patient orprescriber factors.Methods: Retrospective cohort study. Members of ahealth maintenance organization identified ashaving spirometry-defined COPD ranging fromstage II to IV. Electronic medical records werereviewed for documentation of the following: 1)patient affordability issues, 2) history of an adversedrug reaction, 3) history of inefficacy to therapy, and4) prescription history.Results: A total of 111 medical records werereviewed. There were 51% of patients who had notfilled medications that had been prescribed inaccordance with guidelines and 43% did not havethe guideline recommended medications prescribedin the previous year. Only 4% and 2% of patientshad documented inefficacy and affordability issues,respectively. There were no reported cases ofadverse drug reactions.Conclusions: This study provides insight to theacceptance of COPD treatment recommendationsby patients and providers. Further research isneeded to design interventions to reduce barriersand optimize COPD treatment. 2007 artículo científico 1885-642X https://www.redalyc.org/articulo.oa?id=69050204 https://www.redalyc.org/journal/690/69050204/ https://www.redalyc.org/journal/690/69050204/html/ https://www.redalyc.org/journal/690/69050204/69050204.epub https://www.redalyc.org/journal/690/69050204/movil en http://www.redalyc.org/revista.oa?id=690 Pharmacy Practice application/pdf Centro de investigaciones y Publicaciones Farmacéuticas Pharmacy Practice (España) Num.2 Vol.5